EcoDrugPlus

Integrin Beta-3-Like

Ensembl ID : ENSMAMG00000022238
Gene Symbol: LOC113140964
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSMAMG00000018781
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSMAMG00000011841
Gene Symbol: ITGB1
4 Cross references
228 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSMAMG00000015815
Gene Symbol: ITGB3
2 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSMAMG00000004999
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSMAMG00000010121
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha 2b

Ensembl ID : ENSMAMG00000023250
Gene Symbol: ITGA2B
2 Cross references
190 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSMAMG00000002623
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSMAMG00000016310
Gene Symbol: ITGAV
2 Cross references
237 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSMAMG00000014352
Gene Symbol: ITGB1A
3 Cross references
213 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSMAMG00000002229
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSMAMG00000023174
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).